Advertisement
Australia markets closed
  • ALL ORDS

    7,975.10
    -64.80 (-0.81%)
     
  • AUD/USD

    0.6644
    +0.0000 (+0.01%)
     
  • ASX 200

    7,733.70
    -62.30 (-0.80%)
     
  • OIL

    80.88
    +0.15 (+0.19%)
     
  • GOLD

    2,338.30
    +7.10 (+0.30%)
     
  • Bitcoin AUD

    92,431.67
    -4,377.81 (-4.52%)
     
  • CMC Crypto 200

    1,266.07
    -43.65 (-3.33%)
     

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that INOVIO's President and CEO, Dr. Jacqueline Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.

(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)
(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)

The fireside chat will take place on Tuesday, June 11, 2024, at 11:00am ET. This event is only available to institutional clients of Stephens. Please reach out to your Stephens contact for event details.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

ADVERTISEMENT

Contacts
Media: Jennie Willson, (267) 429-8567, jennie.willson@inovio.com
Investors: Thomas Hong, (267) 440-4298, thomas.hong@inovio.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-virtual-fireside-chat-hosted-by-stephens-inc-302162633.html

SOURCE INOVIO Pharmaceuticals, Inc.